Long peptide vaccine 7
Term · Oncology and biomedicine · MLC-T-ONC-014881
A peptide vaccine consisting of a combination of seven synthetic long peptides (SLPs), which are each about 30 amino acids in size, and derived from cancer-testis antigens (CTA) and melanocytic differentiation proteins (MDP), with potential immunostimulating and antitumor activities. Upon administration, long peptide vaccine 7 may stimulate the host immune system to mount a cytotoxic T-cell lymphocyte (CTL) response against tumor cells expressing these peptides. CTA and MDP are overexpressed in a variety of cancer cell types.
| Identifier | MLC-T-ONC-014881 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | LPV7 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014881",
"term": "Long peptide vaccine 7",
"field": "Oncology and biomedicine",
"definition": "A peptide vaccine consisting of a combination of seven synthetic long peptides (SLPs), which are each about 30 amino acids in size, and derived from cancer-testis antigens (CTA) and melanocytic differentiation proteins (MDP), with potential immunostimulating and antitumor activities. Upon administration, long peptide vaccine 7 may stimulate the host immune system to mount a cytotoxic T-cell lymphocyte (CTL) response against tumor cells expressing these peptides. CTA and MDP are overexpressed in a variety of cancer cell types.",
"abbreviation": "LPV7",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/long-peptide-vaccine-7/"
}
Record 10,292 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.